0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Other Articles |

AEROSOL STREPTOMYCIN TREATMENT OF ADVANCED PULMONARY TUBERCULOSIS IN CHILDREN

JOSEPH B. MILLER, M.D.; HAROLD A. ABRAMSON, M.D.; BRET RATNER, M.D.
Am J Dis Child. 1950;80(2):207-237. doi:10.1001/archpedi.1950.04040020216002.
Text Size: A A A
Published online

STREPTOMYCIN has proved effective in inhibiting the growth of tubercle bacilli in vitro, in animal tuberculosis and in acute exudative, in miliary and in surface lesions of human tuberculosis. It is much less effective in the presence of caseation, in patients whose organisms have developed streptomycin resistance and in tuberculosis of certain organs, such as the brain, bones, lymph nodes and kidneys.1 This raises questions concerning the factors influencing the reaction between the organism and the antibiotic and suggests methods of improving the treatment of tuberculosis by altering these factors.

One of the crucial factors in this reaction is the concentration of the antibiotic. By employment of the aerosol route of administration, extremely high concentrations of streptomycin may be introduced into the lungs without discomfort and without the consequent danger of toxic blood levels. This route of administration has a further advantage in that certain substances may be added

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

Correspondence

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();